MEI Pharma Correlations
| MEIPDelisted Stock | USD 3.07 0.18 6.23% |
The correlation of MEI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
MEI Pharma Correlation With Market
Poor diversification
The correlation between MEI Pharma and DJI is 0.76 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MEI Pharma and DJI in the same portfolio, assuming nothing else is changed.
MEI |
Moving together with MEI Stock
| 0.65 | MBFJF | Mitsubishi UFJ Financial | PairCorr |
| 0.68 | MZHOF | Mizuho Financial | PairCorr |
| 0.66 | SBKO | Summit Bank Group | PairCorr |
| 0.73 | ESCA | Escalade Incorporated | PairCorr |
| 0.73 | MFGCF | Mayfair Gold Corp | PairCorr |
| 0.75 | NTRSO | Northern Trust | PairCorr |
| 0.7 | POGS | Pioneer Oil Gas | PairCorr |
| 0.67 | SOJE | Southern Company | PairCorr |
| 0.71 | CMI | Cummins | PairCorr |
| 0.63 | VHI | Valhi Inc Earnings Call This Week | PairCorr |
Moving against MEI Stock
| 0.5 | PBCRY | Bank Central Asia | PairCorr |
| 0.33 | EYPT | Eyepoint Pharmaceuticals Earnings Call This Week | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MEI Stock performing well and MEI Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MEI Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MTVA | 6.40 | (1.96) | 0.00 | (20.08) | 0.00 | 11.60 | 79.95 | |||
| TRAW | 6.65 | (0.20) | 0.00 | (0.13) | 0.00 | 17.44 | 48.86 | |||
| ELEV | 3.37 | 0.26 | 0.05 | 0.58 | 3.35 | 9.09 | 29.95 | |||
| PHXM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PIRS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| DOMH | 3.30 | (0.52) | 0.00 | (0.18) | 0.00 | 5.56 | 25.09 | |||
| KA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NYMXF | 9.55 | 0.43 | 0.01 | (0.08) | 11.28 | 36.54 | 82.03 | |||
| CSCI | 9.42 | 1.57 | 0.11 | 0.87 | 10.60 | 36.74 | 94.83 | |||
| LSB | 5.13 | 0.15 | 0.01 | 0.21 | 8.14 | 12.33 | 91.99 |
Delisting Warning - MEIP
MEI Pharma was delisted
| The entity MEI Pharma with a symbol MEIP was delisted from NASDAQ Exchange. Please try Lite Strategy with a symbol LITS from now on. Check all delisted instruments accross multiple markets. |
MEI Pharma Corporate Management
| BA Esq | COO Counsel | Profile | |
| Anne Frese | Chief Officer | Profile | |
| Eugene Park | VP Marketing | Profile | |
| Virginia Sankey | VP Fin | Profile | |
| JD Esq | Chief Officer | Profile | |
| Eric Deng | VP Operations | Profile |
Still Interested in MEI Pharma?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.